GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Works Technologies AB (XSAT:BIOWKS) » Definitions » Scaled Net Operating Assets

Bio-Works Technologies AB (XSAT:BIOWKS) Scaled Net Operating Assets : 0.15 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bio-Works Technologies AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bio-Works Technologies AB's operating assets for the quarter that ended in Dec. 2024 was kr18.22 Mil. Bio-Works Technologies AB's operating liabilities for the quarter that ended in Dec. 2024 was kr7.91 Mil. Bio-Works Technologies AB's Total Assets for the quarter that ended in Sep. 2024 was kr66.92 Mil. Therefore, Bio-Works Technologies AB's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.15.


Bio-Works Technologies AB Scaled Net Operating Assets Historical Data

The historical data trend for Bio-Works Technologies AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Works Technologies AB Scaled Net Operating Assets Chart

Bio-Works Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.13 0.02 0.05 0.17

Bio-Works Technologies AB Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.14 0.28 0.15

Competitive Comparison of Bio-Works Technologies AB's Scaled Net Operating Assets

For the Biotechnology subindustry, Bio-Works Technologies AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Works Technologies AB's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Works Technologies AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Bio-Works Technologies AB's Scaled Net Operating Assets falls into.


;
;

Bio-Works Technologies AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Bio-Works Technologies AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(18.218-7.913)/62.152
=0.17

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=52.497 - 34.279
=18.218

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=7.913 - 0 - 0
=7.913

Bio-Works Technologies AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(18.218-7.913)/66.922
=0.15

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=52.497 - 34.279
=18.218

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=7.913 - 0 - 0
=7.913

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Works Technologies AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Bio-Works Technologies AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Works Technologies AB Business Description

Traded in Other Exchanges
Address
Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.

Bio-Works Technologies AB Headlines

No Headlines